WinchesterP.D., SenerS.F., KhandekarJ.D.. Symptomatology as an indicator of recurrent or metastatic breast cancer.Cancer1979; 43: 956–60.
2.
HortonJ.Follow-up of breast cancer patients.Cancer1984; 53: 790–7.
3.
Rosselli Del TurcoM., PalliD., CariddiA.. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial.JAMA1994; 271: 1593–7.
4.
GIVIO.Impact of follow-up testing on survival and health-related quality of life in breast cancer patients.JAMA1994; 271: 1587–92.
5.
TomiakE., PiccartM.Routine follow-up of patients after primary therapy for early breast cancer.Ann Oncol1993; 4: 199–204.
6.
KaganA.R., SteckelR.J.Routine imaging studies for the posttreatment surveillance of breast and colorectal carcinoma.J Clin Oncol1991; 9: 837–42.
7.
TominR., DoneganW.L.Screening for recurrent breast cancer: its effectiveness and prognostic value.J Clin Oncol1987; 5: 62–7.
8.
RutgersEJTH, van SlootenE.A., KluckH.M.Follow-up after treatment of primary breast cancer.Br J Surg1989; 76: 187–90.
9.
CiattoS., Rosselli Del TurcoM., PaciniP.. Early detection of local recurrences in the follow-up of primary breast cancer.Tumori1984; 70: 179–83.
10.
TubianaM., KoscienlyS.Kinetics, growth rate and the natural history of breast cancer. The Henson Memorial Lecture.Eur J Cancer Clin Oncol1988; 24: 9–14.
11.
ZwavelingA., AlbersG.H.R., FelthiusW., HermansJ.An evaluation of routine follow-up for detection of breast cancer recurrences.J Surg Oncol1987; 34: 194–7.
12.
CiattoS., Herd-SmithA.The role of chest x-ray in the follow-up of primary breast cancer.Tumori1983; 69: 151–4.
13.
ColemannR.E., FogelmanI., HabibollahiF., NorthW.R.S., RubensR.D.Selection of patients with breast cancer for routine follow-up bone scans.Clin Oncol (R Coll Radiol)1990; 2: 328–32.
14.
NicoliniA., CarpiA., Di MarcoG., GiulianiL., GiordaniR., PallaS.A rational post-operative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients.Cancer1989; 63: 2037–46.
15.
NicoliniA., ColombiniC., LucianiL., CarpiA., GiulianiL.Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.Br J Cancer1991; 64: 154–8.
16.
IwaseH., KobayashiS., ItohY.. Evaluation of serum tumor markers in patients with advanced or recurrent breast cancer.Breast Cancer Res Treat1994; 33: 83–8.
17.
MerimskyO., InbarM., HareuveniM., WitenbergB., WolmanY., Chaitchik. Serial serum MCA measurements in the follow-up of breast cancer patients.Eur J Cancer1991; 27: 1440–4.
18.
ChanD.W., BeveridgeR., BruzekD.J.. Monitoring breast cancer with CA 549.Clin Chem1988; 34: 2000–4.
19.
ASCO tumor marker expert panel. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer.J Clin Oncol1996; 14: 2843–77.
20.
VeronesiA., TalaminiR., LonghiS.. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.Tumori1982; 68: 477–80.
21.
LutgensM., SchlegelG.CEA + TPA in clinical tumor diagnosis with special reference to breast cancer.Tumor Diagnostik1980; 2: 63–77.
22.
TouitouY., BogdanA.Tumor markers in non malignant diseases.Eur J Cancer Clin Oncol1988; 24: 1083–91.
23.
NicoliniA., FerdeghiniM., ColombiniC., CarpiA.Evaluation of serum CA 549, CA M26 and CA M29 levels in the post-operative follow-up of breast cancer patients.J Nucl Med All Sci1990; 34: 309–13.
24.
NicoliniA., FerdeghiniM., ColizziC.Evaluation of CEA, TPA, CA15-3, CA 549 and TPS in the monitoring of metastatic breast cancer.J Nucl Biol Med1993; 37: 126–33.
25.
NicoliniA., AnselmiL., MichelassiC., CarpiA.Prolonged survival by “early” salvage treatment of breast cancer patients: a retrospective 6-year study.Br J Cancer1997; 76: 1106–11.
26.
LogagerV.B., VestergaardA., HerrstedtJ., ThomsenH.S., ZedelerK., DombernowskyP.The limited value of routine chest x-ray in the follow-up of stage II breast cancer.Eur J Cancer1990; 26: 553–5.
27.
GielenF., DequekerJ., DrochmansA., WildiersJ., MerlevedM.Relevance of hydroxyproline excretion to bone metastasis in breast cancer.Br J Cancer1976; 34: 279–84.
28.
ColmanL.K., PorterB.A., RedmondJIII. Early diagnosis of spinal metastases by CT and MR studies.J Comput Assist Tomogr1988; 12: 423–6.
29.
CiattoS., Rosselli Del TurcoM., PaciniP.. Early detection of breast cancer recurrences through periodic follow-up - is it useless?
30.
LoprinziC.L.Follow-up testing for curatively treated cancer survivors.What to do? JAMA1995; 273: 1877–8.
31.
VirgoK.S.The costs of cancer patient follow-up post-treatment.ASCO Educational Book1996; 328–9.
